Theraflu 500 mg/6,1 mg/100 mg tvrde kapsule
| Name | Theraflu 500 mg/6,1 mg/100 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-793678808 |
| Active Substance | paracetamol fenilefrinklorid gvaifenezin |
| Composition | svaka kapsula sadrži 500 mg paracetamola, 6,1 mg fenilefrinklorida (što odgovara 5 mg fenilefrin baze) i 100 mg gvaifenezina |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Haleon Germany GmbH, München, Njemačka Haleon Alcala S.A., Alcala de Henares, Madrid, Španjolska |
| Marketing Authorisation Holder | Haleon Hungary Kft, Csörsz Utca 43, Budimpešta, Mađarska |
| Marketing Authorisation Date | 17.05.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/53 |
| Registration Number | 381-12-01/70-24-39 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | N02BE51 |
| Marketing status | trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
